Results 201 to 210 of about 12,086 (333)

Eating difficulties among Nigerian community-dwelling stroke survivors: prevalence, correlates, and association with quality of life. [PDF]

open access: yesBMC Public Health
Ademoyegun AB   +7 more
europepmc   +1 more source

Early Levodopa Therapy in Tyrosine Hydroxylase Deficiency

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Claudio M. de Gusmao   +4 more
wiley   +1 more source

Is Dysphagia in Multiple System Atrophy Responsive to Levodopa? Results from a Retrospective Study

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Dysphagia remains a major clinical concern in multiple system atrophy (MSA), and so far, lacks relevant treatment options. Objective To systematically assess levodopa‐responsiveness of dysphagia in MSA. Methods 19 MSA‐patients underwent endoscopic swallowing evaluation in Off‐ and On‐state, following an adapted FEES‐levodopa‐test ...
Florin Gandor   +10 more
wiley   +1 more source

The swallow, a target to follow the restauration of consciousness in acquired brain injury. [PDF]

open access: yesJ Rehabil Med
Lerick AC   +6 more
europepmc   +1 more source

Blepharospasm in GNAO1 Syndrome May Benefit From Botulinum Toxins

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Eleonora Minacapilli   +4 more
wiley   +1 more source

Classifying neurogenic dysphagia as a movement disorder. [PDF]

open access: yesBrain
Jones CA   +3 more
europepmc   +1 more source

The Evolving Landscape of Immunotoxicity: Charting Mechanisms and Future Strategies for Immune Checkpoint Inhibitor Adverse Events

open access: yesMed Research, EarlyView.
ABSTRACT The use of immune checkpoint inhibitors (ICIs) has significantly improved the efficacy of cancer therapy, but their associated immune‐related adverse events (irAEs) can severely compromise treatment safety. This review systematically summarizes the core mechanisms underlying irAEs, which include multi‐organ damage resulting from T‐cell ...
Anqi Lin   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy